Posted on 05 November 2010.
INDIANAPOLIS, Ind. — Eli Lilly and Company (NYSE: LLY) announced that the U.S. Food and Drug Administration (FDA) has approved Cymbalta (duloxetine HCl) for the management of chronic musculoskeletal pain. This has been established in studies in patients with chronic low back pain and chronic pain due to osteoarthritis. This is the fifth indication the […]
Posted in Business News
Posted on 23 April 2008.
CHICAGO, Ill. — Half of back pain sufferers reach for Advil or Aleve for relief, according to a poll conducted by Spine-health.com, a leading Web site for those with back problems. The poll, which ran on www.spine-health.com from March to April 2008, asked 899 consumers which over-the-counter (OTC) pain reliever they prefer for treating back […]
Posted in Community News